ELYM Eliem: Net earnings per share for the last 12 months

Public company logo of Eliem Therapeutics, Inc. (ELYM)

Eliem Therapeutics' reliance on outsourcing molecule synthesis via CMOs drives volatility, as evidenced by the comparable year-over-year growth in EPS TTM. Meanwhile, 18.60 represents the latest reading of this metric. The creation of a neural disorder therapy ecosystem strengthens the issuer's position, while a high reputation among neurobiologists in the field of insomnia treatment ensures the loyalty of specialized investors.

Eliem - ELYM Net earnings per share for the last 12 months (period 02/11/2024 - 02/20/2024)

Eliem - analytical breakdowns and key metrics (ELYM)

Initial company analysis:Eliem Therapeutics, Inc. ELYM
Product sample of Eliem Therapeutics, Inc.

This metric is sensitive to the dynamics of operating expenses and net income, measuring the annual growth rate of earnings per share over a rolling period. For Eliem Therapeutics (ELYM), the absence of proprietary manufacturing plants and the reliance on external drug synthesis directly impact margins. The efficiency of outsourcing determines the final profitability. By analyzing the YoY EPS change on a rolling 12-month basis, an investor assesses the sustainability of this business model.

Competitor analysis for Eliem Therapeutics

Net earnings per share for the trailing year Biogen (BIIB)|neurocrine.com (NBIX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Regencell|AXSM (Axsome) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) ACADIA Pharmaceuticals Inc.|Earnings per share for the last twelve months Xenon Pharmaceuticals (XENE)|VKTX (Viking Pharma) - Earnings per share for the trailing year|Earnings per share for the last twelve months Supernus Corp SUPN|Earnings per share for the last four quarters CPRX (Catalyst Pharmaceuticals)|Denali Therapeutics - Net earnings per share (EPS TTM)|HRMY: Earnings per share for the last twelve months|Biohaven (BHVN) - Earnings per share for the last twelve months|Amylyx Pharmaceuticals Inc (AMLX) - Net earnings per share (EPS TTM)|TRVI (Trevi Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Praxis Medicines (PRAX)|Net earnings per share for the last 12 months AVXL (Anavex Life Sciences)|Net earnings per share for the last 12 months CeriBell CBLL|Earnings per share for the last twelve months Prothena Biosciences PRTA|Net earnings per share (EPS TTM) Alector, Inc. ALEC|ANNX - Earnings per share for the last twelve months|OMER - Net earnings per share (EPS TTM)|Neurogene (NGNE) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months AC Immune SA (ACIU)|Net earnings per share for the last 12 months VYGR|Net earnings per share (EPS TTM) Neumora Therapeutics Inc|Earnings per share for the last twelve months scilexholding.com (SCLX)|Net earnings per share for the last four quarters Tevogen Bio Inc.|Earnings per share for the last twelve months Alpha Cognition Inc. ACOG|Net earnings per share (EPS TTM) Cognition Therapeutics CGTX|IKT: Net earnings per share for the last 12 months|SAVA (Cassava Sciences) - Earnings per share for the last 12 months|Assertio Holdings, Inc. (ASRT) - Earnings per share for the last twelve months|Earnings per share for the last 12 months COYA|Earnings per share for the last twelve months Vistagen|Net earnings per share for the last 12 months Ovid Therapeutics (OVID)|Earnings per share for the last twelve months Acumen Pharmaceuticals Inc. (ABOS)|CRVO - Net earnings per one share for the last twelve months|Alterity Therapeutics Limited - Net earnings per share for the last 12 months|CLNN: Earnings per share for the last 12 months|pepgen.com - Net earnings per share (EPS TTM)|JUNS (Jupiter Neurosciences) - Earnings per share for the last 12 months|Relmada (RLMD) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Annovis Bio (ANVS)|GRCE (gracetx.com) - Net earnings per share (EPS TTM)|Firefly Neuroscience Inc (AIFF) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months KLTO (Klotho Neurosciences Inc)|NeuroSense Therapeutics Ltd - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) RVPH (Reviva Pharmaceuticals, Inc.)|Earnings per share for the trailing year MTVA|NeurAxis Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Helius Medical Technologies, Inc. HSDT|PASG: Net earnings per share (EPS TTM)|Neuphoria (NEUP) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Minerva Neurosciences Inc|Athira Pharma Inc (ATHA) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months ADXN (Addex Therapeutics)|Net earnings per share (EPS TTM) Alzamend Neuro Inc. (ALZN)|Cyclerion Therapeutics, Inc. - Net earnings per share for the last 12 months|PTIX (Protagenic Therapeutics) - Earnings per one share for the last 12 months|Pasithea Therapeutics Corp - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Cortigent CRGT|ATXI (Avenue Therapeutics, Inc) - Net earnings per share for the last 12 months|Brainstorm Cell Therapeutics, Inc. - Earnings per share for the trailing year|Net earnings per share for the last 12 months CARA|Net earnings per one share for the last twelve months chromocell.com CHRO|Earnings per share for the last twelve months Intra-Cellular Therapies Inc. (ITCI)|Longboard Pharmaceuticals, Inc. - Earnings per share for the last 12 months|Marinus Pharmaceuticals Inc - Net earnings per share for the last 12 months|NKGen (NKGN) - Net earnings per one share for the last twelve months|NRBO - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months sagerx.com|SNPX: Net earnings per share (EPS TTM)|Trevena Inc. (TRVN) - Net earnings per share (EPS TTM)|VIGL (Vigil Neuroscience, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months WENA (Anew Medical, Inc.)|Net earnings per share (EPS TTM) CERE